Immune checkpoint inhibitors in ovarian cancer: where do we go from here?Won-Hee Yoon, Lawrence Kasherman, Anna DeFazio|Cancer Drug Resistance|2023Cited by 27
Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studiesAinhoa Madariaga, Amit M. Oza, Manuel Alva et al.|International Journal of Gynecological Cancer|2024Cited by 1
Proactive assessment of patient reported outcomes in patients with ovarian cancer.Ainhoa Madariaga, Amit M. Oza, Rodrigo Sánchez-Bayona et al.|Journal of Clinical Oncology|2023Cited by 0